Skip to main content
SpringerLink
Log in

Voriconazole-induced periostitis in stem cell transplant patient

  • Images in Infection
  • Published:
Infection Aims and scope Submit manuscript

A Correction to this article was published on 19 June 2020

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Change history

  • 19 June 2020

    The original version of this article unfortunately contained a mistake

References

  1. Wermers RA, Cooper K, Razonable RR, et al. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy. Clin Infect Dis. 2011;52:604–11.

    CAS  PubMed  Google Scholar 

  2. Bucknor MD, Gross AJ, Link TM. Voriconazole-induced periostitis in two post-transplant patients. J Radiol Case Rep. 2013;7:10.

    PubMed  PubMed Central  Google Scholar 

  3. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis. 2003;36:630–7.

    CAS  PubMed  Google Scholar 

  4. Barajas MR, McCullough KB, Merten JA, et al. Correlation of pain and fluoride concentration in allogeneic hematopoietic stem cell transplant recipients on voriconazole. Biol Blood Marrow Transpl. 2016;22:579–83.

    CAS  Google Scholar 

  5. Moon WJ, Scheller EL, Suneja A, et al. Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain. Clin Infect Dis. 2014;59:1237–45.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Gerber B, Guggenberger R, Fasler D, et al. Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole. Blood. 2012;120(12):2390–4.

    CAS  PubMed  Google Scholar 

  7. Levine MT, Chandrasekar PH. Adverse effects of voriconazole: over a decade of use. Clin Transpl. 2016;30:1377–86.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA

    Alexandre E. Malek & Victor E. Mulanovich

  2. Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center At Houston, Houston, TX, USA

    Alexandre E. Malek

  3. Department of Internal Medicine, The Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon

    Yara Skaff

Authors
  1. Alexandre E. Malek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yara Skaff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Victor E. Mulanovich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexandre E. Malek.

Ethics declarations

Conflict of interest

All authors declare no competing interests.

Additional information

The original version of this article was revised: The spelling of Yara Skaff’s name was incorrect. The corrected author list is given above.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Malek, A.E., Skaff, Y. & Mulanovich, V.E. Voriconazole-induced periostitis in stem cell transplant patient. Infection 48, 809–810 (2020). https://doi.org/10.1007/s15010-020-01445-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-020-01445-0

Keywords

Search

Navigation